Skip to content
Screener

CVS Health CVS Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents

Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents at other companies

Lineage, Inc. logo
Lineage, Inc.LINE
$58M-29.3%
TETRA Technologies logo
TETRA TechnologiesTTI
$154.63M+125%
Taboola.com Ltd. logo
Taboola.com Ltd.TBLA
$133.05M+15.5%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$556.82M+4.3%
CVS Health logo
CVS HealthCVS
$11.54B-4.1%
Walt Disney logo
Walt DisneyDIS
$5.3B-3.2%

Other financials

Income statement

See full
Revenue$106.10B+7.3%
Gross profit$47.2B+5.2%
Operating income$4.7B+97.5%
Net income$3.0B+192%
EPS (diluted)$2.31+189%

Balance sheet

See full
Cash & equivalents$11.5B-4.1%
Total debt$74.3B+286%
Total equity$79.7B+3.0%
Total assets$253.77B-1.8%

Cash flow

See full
Operating cash flow$6.3B+234%
CapEx$691.0M+13.8%
Free cash flow$5.7B+338%

Valuation

See full
Market cap$126.47B+57.0%
Enterprise value$189.28B+116%
P/E25.9×+8.1×
P/S0.3×+0.1×

Profitability

See full
Gross margin44.5%-0.3pp
Operating margin2%-0.3pp
Net margin1.2%0.0pp
FCF margin2.8%

Returns & leverage

See full
Return on equity6.2%+0.3pp
Debt / equity0.9×+0.7×
Current ratio0.9×+0.1×

Where this comes from

Reported directly by CVS Health in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: CVS Health’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:33 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000064803-26-000098
In millionsSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Dividends paid(1,725)(1,706)
Proceeds from exercise of stock options217191
Payments for taxes related to net share settlement of equity awards(154)(125)
Other(62)(45)
Net cash used in financing activities(5,011)(1,526)
Net increase in cash, cash equivalents and restricted cash2,8253,141
Cash, cash equivalents and restricted cash at the beginning of the period8,7128,884
Cash, cash equivalents and restricted cash at the end of the period$11,537$12,025

Item 1.Financial Statements

FAQ

What is CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents?
CVS Health (CVS) reported cash, cash equivalents, restricted cash, and restricted cash equivalents of $11.54B in Q2 2026.
How has CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents changed year-over-year?
CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents decreased by 4.1% year-over-year, from $12.03B to $11.54B.
What is the long-term trend for CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents?
Over 5 years (2020 to 2025), CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents has grown at a -4.6% compound annual growth rate (CAGR), from $11.04B to $8.71B.
What does cash, cash equivalents, restricted cash, and restricted cash equivalents mean?
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents as reported by CVS HEALTH CORPORATION.

Ask your AI about CVS Health's cash, cash equivalents, restricted cash, and restricted cash equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude